key: cord-0748046-tjhesch0 authors: Mahmoud, D. S.; Ibrahim, M. E.; Ganesan, S.; Thakre, D. B.; Teddy, D. J.; Raheja, M. P.; Zaher, D. W. title: Evaluation of RNA extraction free method for detection of SARS-COV-2 in salivary samples for mass screening for COVID-19 date: 2021-03-17 journal: nan DOI: 10.1101/2021.03.15.21253570 sha: 2a717b692968ced903568e783f78341d64e0b0ab doc_id: 748046 cord_uid: tjhesch0 In this current COVID 19 pandemic, there is a dire need for cost effective and less time-consuming alternatives for SARS-COV-2 testing. The RNA extraction free method for detecting SARS COV 2 in saliva is a promising option, this study found that it has high sensitivity (85.34%), specificity (95.04%) and was comparable to the gold standard nasopharyngeal swab. The method showed good percentage of agreement (kappa coefficient) 0.797 between salivary and NPS samples. However, there are variations in the sensitivity and specificity based on the RT-PCR kit used. The Thermo Fischer- Applied biosystems showed high sensitivity, PPV and NPV but also showed higher percentage of invalid reports. Whereas the BGI kit showed high specificity, better agreement (kappa coefficient) between the results of saliva and NPS samples and higher correlation between the Ct values of saliva and NPS samples. Thus, the RNA extraction free method for salivary sample serves as an effective alternative for SARS CoV 2 testing. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 17, 2021. Methodology 70 Sample size calculation 71 The SARS-COV-2 infection positivity was around 5% in our lab, at the time of the study. With 72 the recommendation based on Bujang et al [14] we calculated the minimum sample size to be 380 73 participants, including 19 positive cases to achieve a minimum power of at least 80%, at a 74 significance level of 5%, to detect a sensitivity of 95%. This sample would also be able to detect 75 a specificity of 95%. The study was approved by the Department of Health (DOH) Institutional review board (IRB), 78 Abu Dhabi. The study followed all regulations and guidelines of the IRB. The participants of the 79 study were well-informed about the details of the study and informed consent was obtained. After 80 obtaining the consent from the participants, one nasopharyngeal swab (NPS) and salivary sample 81 was collected from each participant. Totally 600 people participated in the study. The NPS samples 82 were collected by trained healthcare personnel as per protocol in place and were immediately 83 transported to the lab. The salivary samples were collected in a sterile Dnase/Rnase free container 84 without any stabilizing agent. Instructions were given to all the participants before saliva 85 collection. The preconditions for saliva collection include no food, drinks, smoke nor oral hygiene 86 products in the last one hour prior to sample collection. Participants were asked to pool saliva in 87 their mouth for 1-2 minutes. The collected salivary samples were transported to the lab, in 88 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is a nucleic acid extraction free method for SARS-COV-2 detection following the protocol of 92 Saliva-Direct test, a saliva-based, nucleic-acid-extraction-free, qRT-PCR method for SARS-CoV-93 2 detection [15] . The Saliva sample collected is first treated with proteinase K followed by a heat 94 inactivation step and is then directly used as input in the RT-qPCR test using validated primer and 101 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The qPCR procedure was performed following manufacturer's instructions and was optimized for To compare the efficiency of RNA extraction free method of salivary sample in RT-PCR based 122 testing with BGI RT-PCR kit and Thermo fischer/ Applied Biosystems RT-PCR Kit, 258 random 123 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The sensitivity, specificity, PPV, NPV and the percentage of agreement (kappa agreement %) 153 between the two different kits were calculated and compared. [ Figure 2 ]. There was statistically 154 significant difference between the two kits in terms of sensitivity, PPV, agreement percentage and 155 the percentage of invalid results.[ Table 4 ] All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The study showed that the saliva RT-PCR (RNA extraction free method) has high sensitivity and 174 specificity and is comparable to the gold standard nasopharyngeal swab (NPS). Studies reported 175 earlier have shown similar results, where the sensitivity of saliva samples in detecting SARS-176 COV-2 ranges from 73% to 91% and the specificity ranges from 97 % to 98.9% [18, 19, 20] . In our study the PPV (91.6%) and NPV (91.03%) was high for direct (RNA extraction free 178 method) saliva testing and similar results have been reported in other studies also [18, 20] . (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Hence the study shows that saliva can be a reliable alternative for SARS-COV-2 testing and 213 similar studies have shown saliva to be a reliable sample even without the RNA extraction process. [28] . As the sensitivity and the PPV of the saliva sample is high and comparable to NPS sample, 215 this method can be highly useful in identifying patients early and isolating them to limit spread. 216 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The strength of this study is that it not only evaluates the RNA extraction free method for molecular 225 testing of SARS-COV-2 of salivary sample, but also validates and compares different RT -PCR 226 kits for extraction free method of saliva sample. Not many studies have evaluated these. Limitation of this study is that the study did not consider the number of days the patient has been (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. World Health Organization (WHO) Coronavirus disease (COVID-19) Dashboard. flexible platform to enhance SARS-CoV-2 testing capacity SalivaDirect: A simplified and flexible platform 302 to enhance SARS-CoV-2 testing capacity Applied Biosystems. Thermo fisher TaqPath™ COVID-19 CE-IVD RT-PCR Kit 307 Instructions for use Assets/LSG/manuals/MAN0019215_TaqPathCOVID-19_CE-IVD_RT Saliva as 312 an Alternative Specimen for Molecular COVID-19 Testing in Community Settings Population-Based Screening Saliva as a Candidate for COVID-19 Diagnostic Testing: 317 A Meta-Analysis. medRxiv PCR inhibitors -occurrence, properties 346 and removal Efficacy of a novel SARS-CoV-2 detection kit without 350 RNA extraction and purification Massive and rapid COVID-19 testing is feasible 353 by extraction-free SARS-CoV-2 RT-PCR